• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Onconetix, Inc. - Common Stock (NQ:ONCO)

3.030 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 42,536
Open 3.030
Bid (Size) 3.080 (100)
Ask (Size) 3.300 (200)
Prev. Close 3.030
Today's Range 3.030 - 3.030
52wk Range 0.4395 - 14.86
Shares Outstanding 22,171,931
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration
March 25, 2026
From Onconetix, Inc.
Via GlobeNewswire
News headline image
Onconetix, Inc. Announces 1-for-5 Reverse Stock Split
March 23, 2026
From Onconetix, Inc.
Via GlobeNewswire

Performance

YTD
+88.2%
+88.2%
1 Month
+356.6%
+356.6%
3 Month
+99.3%
+99.3%
6 Month
-4.4%
-4.4%
1 Year
-63.9%
-63.9%

More News

Read More
What's going on in today's after hours session ↗
March 20, 2026
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
February 13, 2026
Via Chartmill
News headline image
Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company
February 12, 2026
From Onconetix, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
September 26, 2025
Via Benzinga
News headline image
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
September 26, 2025
From Onconetix, Inc.
Via GlobeNewswire
News headline image
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement
September 26, 2025
From Onconetix, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 22, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 22, 2025
Via Benzinga
News headline image
Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM
September 22, 2025
From Onconetix, Inc.
Via GlobeNewswire
News headline image
Friday's after hours session: top gainers and losers ↗
August 08, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
July 31, 2025
Via Benzinga
News headline image
Thursday's session: gap up and gap down stocks ↗
July 31, 2025
Via Chartmill
News headline image
Discover the top movers in Thursday's pre-market session. ↗
July 31, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
July 31, 2025
Via Benzinga
News headline image
Why Meta Platforms Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
July 31, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
July 25, 2025
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-07-16: top gainers and losers in today's session. ↗
July 16, 2025
Via Chartmill
News headline image
Dow Surges Over 100 Points; Goldman Sachs Posts Upbeat Earnings ↗
July 16, 2025
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
July 16, 2025
Via Benzinga
News headline image
US Stocks Mixed; Bank of America Earnings Top Views ↗
July 16, 2025
Via Benzinga
News headline image
ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders
July 16, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
July 16, 2025
Via Chartmill
News headline image
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
July 16, 2025
From Onconetix, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Onconetix, Inc. - Common Stock publicly traded?
Yes, Onconetix, Inc. - Common Stock is publicly traded.
What exchange does Onconetix, Inc. - Common Stock trade on?
Onconetix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Onconetix, Inc. - Common Stock?
The ticker symbol for Onconetix, Inc. - Common Stock is ONCO on the Nasdaq Stock Market
What is the current price of Onconetix, Inc. - Common Stock?
The current price of Onconetix, Inc. - Common Stock is 3.030
When was Onconetix, Inc. - Common Stock last traded?
The last trade of Onconetix, Inc. - Common Stock was at 03/25/26 04:00 PM ET
What is the market capitalization of Onconetix, Inc. - Common Stock?
The market capitalization of Onconetix, Inc. - Common Stock is 67.18M
How many shares of Onconetix, Inc. - Common Stock are outstanding?
Onconetix, Inc. - Common Stock has 67M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap